In this issue:
Tapinarof cream for plaque psoriasis
COVID-19 vaccination during methotrexate or targeted immunosuppression
Sex and systemic therapy treatment outcomes in psoriasis
Subclinical liver disease and subclinical atherosclerosis in psoriasis
Association of psoriasis with colorectal cancer
Tonsillectomy and the subsequent risk of psoriasis
Comorbid obesity and diabetes associated with response to biologics
Lymphohaematologic malignancies with chronic plaque psoriasis
Secukinumab in paediatric patients with moderate-to-severe plaque psoriasis
Australian cost-utility analysis of biologics for severe, chronic plaque psoriasis
Please login below to download this issue (PDF)